School of Medicine
Showing 461-470 of 1,296 Results
-
Robert W. Shafer
Professor (Research) of Medicine (Infectious Diseases) and, by courtesy, of Pathology
Current Research and Scholarly InterestsMy group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. Our paramount goal is to inform HIV treatment and prevention policies by identifying the main factors responsible for the emergence and spread of drug resistance.
-
Steven L. Shafer, MD
Professor of Anesthesiology, Perioperative and Pain Medicine (Adult MSD) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsPharmacokinetics and pharmacodynamics of intravenous anesthetics, including drug interactions and continuous measures of drug effect; model-based drug development; target controlled drug delivery; advanced models of drug behavior.
-
Elaheh Shaghaghian, MD
Visiting Instructor, Neurosurgery
BioElaheh Shaghaghian, MD, is a Clinical Research Scholar at Stanford University's Neurosurgery Department, where she investigates the efficacy of CyberKnife Radiosurgery with an interdisciplinary team. Skilled in problem-solving, Elaheh has a fervent passion for learning and applying new medical technologies.
She earned her MD from Shiraz University of Medical Sciences, focusing on advancing medical treatments through research. With experience in clinical research, data analysis, and interdisciplinary collaboration, she is dedicated to leveraging technology to enhance healthcare outcomes. -
Ami J. Shah
Clinical Professor, Pediatrics - Stem Cell Transplantation
BioDr. Shah joined Stanford University in 2015 as a Clinical Professor of Pediatrics in the Division of Hematology/ Oncology, Stem Cell Transplantation and Regenerative Medicine. Dr. Shah completed medical school at the University of North Carolina- Chapel Hill. She completed her training in Pediatrics and Pediatric Hematology/ Oncology at Childrens Hospital Los Angeles. Her areas of clinical expertise have been in stem cell transplantation for malignant and non-malignant disorders. She has been actively involved with the care and treatment of children with primary immune deficiencies and is the site PI for the Primary Immune Deficiencies Consortium (PIDTC). She has experience in numerous gene therapy trials for primary immune deficiencies, hemoglobinopathies and other genetic diseases. She has a specific interest in the long term outcomes following HSCT, in specific the neurocognitive function post HSCT. She has been an active participant in American Society of Transplantation and Cellular Therapy (ASTCT), Children's Oncology Group (COG) and American Society of Hematology (ASH).
She has been actively involved with mentorship and graduate medical education, and currently serves as the Program Director for the Pediatric Hematology/ Oncology Fellowship and the Pediatric Stem Cell Fellowship. She also serves on the Pediatric Mentoring Group. -
Arpeet Tarun Shah, MD
Affiliate, Medicine - Med/Oncology
BioDr. Shah practices hematology and oncology. He has fellowship training in both specialties and is board-certified in hematology, oncology, and internal medicine.
Dr. Shah is passionate about delivering patient-centered care. He aims to balance evidence-based treatments with each patient’s individual preferences. His goal is to maximize both clinical outcomes and quality of life.
He feels privileged to have the opportunity to work so closely with patients and their families. Together, they can find and pursue what is important to them throughout their cancer journey.
In addition to providing clinical care, Dr. Shah has conducted research. His research interests include molecular testing and immunotherapy outcomes in patients with non-small cell lung cancer (NSCLC).
Dr. Shah has co-authored articles on treatment for NSCLC and other topics in publications such as Clinical Lung Cancer and Journal of Oncology Practice.
He has made presentations to his peers at the American Society of Clinical Oncology–Society for the Immunotherapy of Cancer (ASCO-SITC) annual meeting and other conferences. He also has helped develop the curriculum and taught students in hematology, oncology, internal medicine, and neurobiology. In his hematology/oncology fellowship at Stanford, he was a senior teaching fellow.
Dr. Shah was also a Johnson & Johnson Global Health Scholar, serving for two months as a visiting resident scholar in Kampala, Uganda.
When not working, he enjoys reading, trying new recipes, and exploring parks with his family.